Overall, the U.S. urological device market was valued at over $2.9 billion in 2018. This is expected to increase over the forecast period at a CAGR of 3.6% to reach $3.8 billion.
As the demand side of the market continues to undergo consolidation, with hospitals acquiring outpatient facilities and expanding the reach of the group purchasing organizations (GPOs), coupled with the reimbursement cuts across the urology space, average selling prices are expected to remain under significant pressure, negatively impacting the future growth of the market.
MARKET REPORT DATA TYPES INCLUDED
COMPANIES ANALYZED
In 2018, the leading competitor in the urological device market was Boston Scientific. The company held the leading positions in the stone management device market, BPH treatment device market and erectile dysfunction market.BARD was the second-leading competitor. The company held the leading position in the urinary incontinence device market, solely attributed to its dominant position in the urinary catheter market. Coloplast was the third-leading competitor. The company held the second-leading positions in the urinary incontinence device market and erectile dysfunction device market.
As the demand side of the market continues to undergo consolidation, with hospitals acquiring outpatient facilities and expanding the reach of the group purchasing organizations (GPOs), coupled with the reimbursement cuts across the urology space, average selling prices are expected to remain under significant pressure, negatively impacting the future growth of the market.
MARKET REPORT DATA TYPES INCLUDED
- Unit Sales, Average Selling Prices, Market Value & Growth Trends
- 10 Year Scope
- Market Drivers & Limiters for Each Segment
- Competitive Analysis with Market Shares for Each Segment
- Recent Mergers & Acquisitions
- Disease Overviews and Demographic Information
- Company Profiles, Product Portfolios and SWOT for Top Competitors
- Related Press Releases from Top Competitors
COMPANIES ANALYZED
In 2018, the leading competitor in the urological device market was Boston Scientific. The company held the leading positions in the stone management device market, BPH treatment device market and erectile dysfunction market.BARD was the second-leading competitor. The company held the leading position in the urinary incontinence device market, solely attributed to its dominant position in the urinary catheter market. Coloplast was the third-leading competitor. The company held the second-leading positions in the urinary incontinence device market and erectile dysfunction device market.
Table of Contents
TABLE OF CONTENTSLIST OF FIGURESLIST OF CHARTSABBREVIATIONS
1. EXECUTIVE SUMMARY
2. DISEASE OVERVIEW
U.S. UROLOGICAL DEVICE MARKET OVERVIEW
4.5 MERGERS AND ACQUISITIONS
5. PROCEDURE NUMBERS
6. URINARY INCONTINENCE DEVICE MARKET
7. STONE MANAGEMENT DEVICE MARKET
8. BPH TREATMENT DEVICE MARKET
9. UROLOGICAL ENDOSCOPE MARKET
10. PROSTATE CANCER TREATMENT DEVICE MARKET
11. URODYNAMIC EQUIPMENT MARKET
12. NEPHROSTOMY DEVICE MARKET
13. ERECTILE DYSFUNCTION DEVICE MARKET
Companies mentioned
- Advanced Endoscopic Devices
- Cooper Surgical
- Aeromed
- Deroyal
- Angiodynamicss
- Direx
- Applied Medical
- Dornier MedTech
- AprioMed
- Dynarex
- Argon Medical
- Eckert & Ziegler BEBIG
- Ashlar
- EDAP TMS
- Augusta Medical Systems
- Electro Medical Systems
- Authentic Option
- Elekta
- BARD
- Galil Medical
- Best Medical
- GE Oncura
- BioDerm
- Healthtronics
- Biolitec
- Hollister
- Boston Scientific
- Innovaquartz
- BR Surgical
- IsoAid
- Calcura Technologies
- IsoRay
- Caldera Medical
- Karl Storz
- Cardinal Health
- LABORIE
- Coloplast
- Laser Peripheral
- Convergent Laser Technologies
- LISA Laser
- Cook Medical
- Lumenis